|
1
|
Trefts E, Gannon M and Wasserman DH: The
liver. Curr Biol. 27:R1147–R1151. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jetter A and Kullak-Ublick GA: Drugs and
hepatic transporters: A review. Pharmacol Res. 154:1042342020.
View Article : Google Scholar
|
|
3
|
Andrade RJ, Chalasani N, Björnsson ES,
Suzuki A, Kullak-Ublick GA, Watkins PB, Devarbhavi H, Merz M,
Lucena MI, Kaplowitz N and Aithal GP: Drug-induced liver injury.
Nat Rev Dis Primers. 5:582019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
European Association for the Study of the
Liver. Electronic address easloffice@easloffice.eu; Clinical
Practice Guideline Panel: Chair:; Panel members; EASL Governing
Board representative: EASL Clinical practice guidelines:
Drug-induced liver injury. J Hepatol. 70:1222–1261. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Saithanyamurthi H and Faust AJ:
Drug-Induced liver disease: Clinical course. Clin Liver Dis.
21:21–34. 2017. View Article : Google Scholar
|
|
6
|
Luedde T, Kaplowitz N and Schwabe RF: Cell
death and cell death responses in liver disease: Mechanisms and
clinical relevance. Gastroenterology. 147:765–783.e4. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Giordano CM and Zervos XB: Clinical
manifestations and treatment of drug-induced hepatotoxicity. Clin
Liver Dis. 17:565–573, viii. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu Y, Zhao P, Cheng M, Yu L, Cheng Z, Fan
L and Chen C: AST to ALT ratio and arterial stiffness in non-fatty
liver Japanese population:a secondary analysis based on a
cross-sectional study. Lipids Health Dis. 17:2752018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shi H, Yan Y, Yang H, Pu P and Tang H:
Schisandrin B diet inhibits oxidative stress to reduce ferroptosis
and lipid peroxidation to prevent pirarubicin-induced
hepatotoxicity. Biomed Res Int. 2022:56235552022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, Ma XY, Zhang T, Qin M, Sun B, Li
Q, Hu DW and Ren LQ: Protective effects of apocynum venetum against
pirarubicin-induced cardiotoxicity. Am J Chin Med. 47:1075–1097.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hori H, Kudoh T, Nishimura S, Oda M,
Yoshida M, Hara J, Tawa A, Usami I, Tanizawa A, Yumura-Yagi K, et
al: Acute and late toxicities of pirarubicin in the treatment of
childhood acute lymphoblastic leukemia: Results from a clinical
trial by the Japan Association of Childhood Leukemia Study. Int J
Clin Oncol. 22:387–396. 2017. View Article : Google Scholar
|
|
12
|
Jiménez-Castro MB, Cornide-Petronio ME,
Gracia-Sancho J and Peralta C: Inflammasome-mediated inflammation
in liver ischemia-reperfusion injury. Cells. 8:11312019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dai C, Xiao X, Li D, Tun S, Wang Y, Velkov
T and Tang S: Chloroquine ameliorates carbon tetrachloride-induced
acute liver injury in mice via the concomitant inhibition of
inflammation and induction of apoptosis. Cell Death Dis.
9:11642018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu YT, Qi SL and Sun KW: Traditional
Chinese medicine, liver fibrosis, intestinal flora: Is there any
connection?-a narrative review. Ann Palliat Med. 10:4846–4857.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen M, Xie Y, Gong S, Wang Y, Yu H, Zhou
T, Huang F, Guo X, Zhang H, Huang R, et al: Traditional Chinese
medicine in the treatment of nonalcoholic steatohepatitis.
Pharmacol Res. 172:1058492021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Serafini M, Peluso I and Raguzzini A:
Flavonoids as anti-inflammatory agents. Proc Nutr Soc. 69:273–278.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Koirala N, Thuan NH, Ghimire GP, Thang DV
and Sohng JK: Methylation of flavonoids: Chemical structures,
bioactivities, progress and perspectives for biotechnological
production. Enzyme Microb Technol. 86:103–116. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yi YS: Regulatory roles of flavonoids on
inflammasome activation during inflammatory responses. Mol Nutr
Food Res. 62:e18001472018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Krych-Madej J, Stawowska K and Gebicka L:
Oxidation of flavonoids by hypochlorous acid: Reaction kinetics and
antioxidant activity studies. Free Radic Res. 50:898–908. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ha SE, Kim SM, Vetrivel P, Kim HH, Bhosale
PB, Heo JD, Lee HJ and Kim GS: Inhibition of cell proliferation and
metastasis by scutellarein regulating PI3K/Akt/NF-κB signaling
through PTEN activation in hepatocellular carcinoma. Int J Mol Sci.
22:88412021. View Article : Google Scholar
|
|
21
|
Russo M, Moccia S, Spagnuolo C, Tedesco I
and Russo GL: Roles of flavonoids against coronavirus infection.
Chem Biol Interact. 328:1092112020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chagas MDSS, Behrens MD, Moragas-Tellis
CJ, Penedo GXM, Silva AR and Gonçalves-de-Albuquerque CF: Flavonols
and flavones as potential anti-inflammatory, antioxidant, and
antibacterial compounds. Oxid Med Cell Longev. 2022:99667502022.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin Y, Ren N, Li S, Chen M and Pu P: Novel
anti-obesity effect of scutellarein and potential underlying
mechanism of actions. Biomed Pharmacother. 117:1090422019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao L, Tang H, Zeng Q, Tang T, Chen M and
Pu P: The anti-insulin resistance effect of scutellarin may be
related to antioxidant stress and AMPKα activation in diabetic
mice. Obes Res Clin Pract. 14:368–374. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Brenner C, Galluzzi L, Kepp O and Kroemer
G: Decoding cell death signals in liver inflammation. J Hepatol.
59:583–594. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cavalli G and Dinarello CA: Suppression of
inflammation and acquired immunity by IL-37. Immunol Rev.
281:179–190. 2018. View Article : Google Scholar
|
|
27
|
Peyrou M, Bourgoin L and Foti M: PTEN in
non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and
cancer. Dig Dis. 28:236–246. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Álvarez-Garcia V, Tawil Y, Wise HM and
Leslie NR: Mechanisms of PTEN loss in cancer: It's all about
diversity. Semin Cancer Biol. 59:66–79. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Piao Y and Yin D: Mechanism underlying
treatment of diabetic kidney disease using Traditional Chinese
Medicine based on theory of Yin and Yang balance. J Tradit Chin
Med. 38:797–802. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yu G, Yu H, Yang Q, Wang J, Fan H, Liu G,
Wang L, Bello BK, Zhao P, Zhang H and Dong J: Vibrio harveyi
infections induce production of proinflammatory cytokines in murine
peritoneal macrophages via activation of p38 MAPK and NF-κB
pathways, but reversed by PI3K/AKT pathways. Dev Comp Immunol.
127:1042922022. View Article : Google Scholar
|
|
31
|
Pu P, Wang XA, Salim M, Zhu LH, Wang L,
Chen KJ, Xiao JF, Deng W, Shi HW, Jiang H and Li HL: Baicalein, a
natural product, selectively activating AMPKα(2) and ameliorates
metabolic disorder in diet-induced mice. Mol Cell Endocrinol.
362:128–138. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
33
|
Sookoian S and Pirola CJ: Liver enzymes,
metabolomics and genome-wide association studies: From systems
biology to the personalized medicine. World J Gastroenterol.
21:711–725. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Korver S, Bowen J, Pearson K, Gonzalez RJ,
French N, Park K, Jenkins R and Goldring C: The application of
cytokeratin-18 as a biomarker for drug-induced liver injury. Arch
Toxicol. 95:3435–3448. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Stravitz RT and Lee WM: Acute liver
failure. Lancet. 394:869–881. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Worby CA and Dixon JE: PTEN. Annu Rev
Biochem. 83:641–669. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ho J, Cruise ES, Dowling RJO and Stambolic
V: PTEN nuclear functions. Cold Spring Harb Perspect Med.
10:a0360792020. View Article : Google Scholar
|
|
38
|
Chen J, Zhang XD and Proud C: Dissecting
the signaling pathways that mediate cancer in PTEN and LKB1
double-knockout mice. Sci Signal. 8:pe12015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tang F, Wang Y, Hemmings BA, Rüegg C and
Xue G: PKB/Akt-dependent regulation of inflammation in cancer.
Semin Cancer Biol. 48:62–69. 2018. View Article : Google Scholar
|
|
40
|
Sun X, Chen L and He Z: PI3K/Akt-Nrf2 and
anti-inflammation effect of macrolides in chronic obstructive
pulmonary disease. Curr Drug Metab. 20:301–304. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mishra V, Banga J and Silveyra P:
Oxidative stress and cellular pathways of asthma and inflammation:
Therapeutic strategies and pharmacological targets. Pharmacol Ther.
181:169–182. 2018. View Article : Google Scholar
|
|
42
|
Mulero MC, Huxford T and Ghosh G: NF-κB,
IκB, and IKK: Integral components of immune system signaling. Adv
Exp Med Biol. 1172:207–226. 2019. View Article : Google Scholar
|
|
43
|
Lin JK: Cancer chemoprevention by tea
polyphenols through modulating signal transduction pathways. Arch
Pharm Res. 25:561–571. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kondylis V, Kumari S, Vlantis K and
Pasparakis M: The interplay of IKK, NF-κB and RIPK1 signaling in
the regulation of cell death, tissue homeostasis and inflammation.
Immunol Rev. 277:113–127. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gasparini C and Feldmann M: NF-κB as a
target for modulating inflammatory responses. Curr Pharm Des.
18:5735–5745. 2012. View Article : Google Scholar
|
|
46
|
Dumortier C, Danopoulos S, Velard F and Al
Alam D: Bone cells differentiation: How CFTR mutations may rule the
game of stem cells commitment? Front Cell Dev Biol. 9:6119212021.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sang Eun H, Seong Min K, Ho Jeong L,
Vetrivel P, Venkatarame Gowda Saralamma V, Jeong Doo H, Eun Hee K,
Sang Joon L and Gon Sup K: Scutellarein induces Fas-mediated
extrinsic apoptosis and G2/M cell cycle arrest in Hep3B
hepatocellular carcinoma cells. Nutrients. 11:2632019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Fu Y, Sun S, Sun H, Peng J, Ma X, Bao L,
Ji R, Luo C, Gao C, Zhang X and Jin Y: Scutellarin exerts
protective effects against atherosclerosis in rats by regulating
the Hippo-FOXO3A and PI3K/AKT signaling pathways. J Cell Physiol.
234:18131–18145. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Nie J, Yang HM, Sun CY, Liu YL, Zhuo JY,
Zhang ZB, Lai XP, Su ZR and Li YC: Scutellarin enhances antitumor
effects and attenuates the toxicity of bleomycin in H22 ascites
tumor-bearing mice. Front Pharmacol. 9:6152018. View Article : Google Scholar : PubMed/NCBI
|
